###begin article-title 0
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
The control of CD4+CD25+Foxp3+ regulatory T cell survival
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 31 34 31 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 230 234 230 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 386 394 386 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 422 430 422 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 454 458 454 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 470 474 470 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 648 650 648 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 817 821 817 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 868 872 868 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1057 1061 1057 1061 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1200 1204 1200 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
CD4+CD25+Foxp3+ regulatory T (Treg) cells are believed to play an important role in suppressing autoimmunity and maintaining peripheral tolerance. How their survival is regulated in the periphery is less clear. Here we show that Treg cells express receptors for gamma chain cytokines and are dependent on an exogenous supply of these cytokines to overcome cytokine withdrawal apoptosis in vitro. This result was validated in vivo by the accumulation of Treg cells in Bim-/- and Bcl-2 tg mice which have arrested cytokine deprivation apoptosis. We also found that CD25 and Foxp3 expression were down-regulated in the absence of these cytokines. CD25+ cells from Scurfy mice do not depend on cytokines for survival demonstrating that Foxp3 increases their dependence on cytokines by suppressing cytokine production in Treg cells. Our study reveals that the survival of Treg cells is strictly dependent on cytokines and cytokine producing cells because they do not produce cytokines. Our study thus, demonstrates that different gamma chain cytokines regulate Treg homeostasis in the periphery by differentially regulating survival and proliferation. These findings may shed light on ways to manipulate Treg cells that could be utilized for their therapeutic applications.
###end p 2
###begin p 3
This article was reviewed by: Avinash Bhandoola, Fred Ramsdell (nominated by Juan Carlos Zuniga-Pflucker) and Anne Cooke.
###end p 3
###begin title 4
Background
###end title 4
###begin p 5
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 17 21 17 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 497 501 497 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 667 671 667 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 804 808 804 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 832 833 832 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 906 910 906 910 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 939 941 939 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 978 982 978 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1063 1067 1063 1067 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1129 1133 1129 1133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1182 1186 1182 1186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1194 1201 1194 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1219 1221 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1222 1224 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1351 1353 1351 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1369 1373 1369 1373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1437 1439 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1440 1442 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1493 1497 1493 1497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1547 1549 1547 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1655 1659 1655 1659 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1666 1668 1666 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1743 1747 1743 1747 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1787 1791 1787 1791 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1890 1899 1890 1899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1903 1910 1903 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1990 1994 1986 1990 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 268 274 <span type="species:ncbi:9606">humans</span>
###xml 438 444 <span type="species:ncbi:9606">humans</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 1648 1653 <span type="species:ncbi:9606">human</span>
CD4+CD25+Foxp3+ Treg cells are a subset of lymphocytes having an anergic phenotype as shown by their absence of proliferation and production of IL-2 upon TCR stimulation. [1,2] They have been shown to suppress various inflammatory and autoimmune responses in mice and humans. Absence of this population of T cells causes an acute autoimmune condition called Immune dysregulation Polyendocrinopathy Enteropathy X-linked syndrome (IPEX) in humans and fatal autoimmune manifestations in mice [3-7]. Treg cells cause cytokine deprivation death by consuming cytokines from CD4 T cells to cause suppressive apoptosis. This is probably one of the default mechanisms of how Treg cells operate in the close vicinity of CD4 T cells [8]. Evidence show that self-peptides are important for homeostatic expansion of Treg cells in the periphery [9]. Despite the abundant availability of self-peptides, the frequency of Treg cells is always 10-15% of CD4+ population. Increase or decrease in Treg numbers would result in immune imbalance as evidenced by suppressive effects of Treg cells on other immune cells. However, parameters controlling Treg cells and their survival maintaining the normal Treg numbers in vivo, remain unclear [10,11]. FAS and TCR restimulation mediated death constitute two of the major mechanisms regulating T cell survival and homeostasis [12-14]. However, Treg cells are shown to be resistant to these active forms of death [15,16]. IL-2 is shown to be a major survival factor of Treg cells, but the role of other cytokines is unknown[17]. One study proposes the role of gamma chain cytokines in regulating the suppressive potential of human Treg cells [18]. However, the direct contribution of these cytokines in the survival of Treg cells remains undocumented. Exploiting Treg cells for therapeutical applications demands a complete understanding of their survival mechanisms in vitro and in vivo. Here we show evidence that common gamma chain cytokines play a major role in Treg survival in the periphery.
###end p 5
###begin p 6
###xml 150 151 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 154 156 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 157 159 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 386 388 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 389 391 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 869 871 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 990 992 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1165 1167 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1168 1170 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1289 1291 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1292 1294 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1295 1297 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1298 1300 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1434 1436 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1437 1439 1391 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1578 1582 1532 1536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1603 1605 1557 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1606 1608 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1768 1776 1718 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1777 1779 1727 1729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1811 1815 1757 1761 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1821 1829 1767 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1866 1870 1812 1816 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1992 1996 1934 1938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2088 2092 2030 2034 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2185 2189 2127 2131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1148 1154 <span type="species:ncbi:9606">humans</span>
###xml 1159 1163 <span type="species:ncbi:10090">mice</span>
###xml 1389 1393 <span type="species:ncbi:10090">mice</span>
###xml 1485 1489 <span type="species:ncbi:10090">mice</span>
###xml 1597 1601 <span type="species:ncbi:10090">mice</span>
###xml 1895 1899 <span type="species:ncbi:10090">mice</span>
Common chain (gammac) cytokines such as IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21, bind to multimeric receptors that share the common gamma chain (gammac) [19-26]. Common gammac is a critical part of the cytokine receptors that confers the ability of as gammac cytokines to activate MAP kinase and PI3 kinase signaling, leading to anti-apoptotic and proliferation signals in lymphocytes [24,27]. For example, IL-2 binds to IL-2R complex consisting of IL-2R-alpha, which possesses a short cytoplasmic domain. IL-2R-alpha binds IL-2 only with low affinity and does not recruit intra cytoplasmic signaling molecules. beta chain (IL-2/15Rbeta), shared by the IL-15 receptor stimulates downstream signaling pathways. However, gammac is the most crucial component of the IL-2 receptor complex, raising its binding affinity for IL-2 and thus initiating a potent IL-2 signaling [28]. gammac chain cytokines are pleiotropic soluble factors crucial for lymphocyte generation, survival and homeostasis [29]. Defects in gammac signaling components result in impaired B, T, and natural killer (NK) cell development, leading to severe combined immunodeficiency in humans and mice [30,31]. The roles of IL-7 and IL-15 in the homeostasis of naive CD4 and memory CD8 cells respectively, are well documented [21,24,32,33]. The importance of IL-2 in lymphocyte homeostasis is shown by a severe autoimmunity in mice deficient in IL-2 signaling components [34,35]. The autoimmune phenotype observed in these mice has been attributed to the loss of cell death mechanism mediated by FAS and absence of Treg cells in these mice [36,37]. Besides maintaining the homeostasis of naive and memory cells, gammac-cytokine signaling plays an important role during differentiation of activated T cells in vivo [25]. How gammac-cytokines impact Treg cells in vivo is not well studied. The absence of Treg cells in gammac-knockout mice seems to suggest that the common gamma chain signaling is important for the development of Treg cells. However, whether these cytokines influence the peripheral survival and expansion of Treg cells is not known. Here we show that gamma chain cytokines are crucial for maintaining the Treg cells in the periphery without which they undergo apoptosis.
###end p 6
###begin title 7
Methods
###end title 7
###begin title 8
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 8
###begin p 9
###xml 20 24 20 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 102 117 <span type="species:ncbi:10090">transgenic mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
BALB/c, C57BL/6, Bim-/- mice and Scurfy mice were purchased from Jackson Laboratories. 129 Foxp3-eGFP transgenic mice were purchased from Taconic farms. CB-17 scid mice were also purchased from Charles River Laboratories. All mice were maintained in NIAID animal facility and cared for in accordance with institutional guidelines.
###end p 9
###begin title 10
Reagents and antibodies
###end title 10
###begin p 11
###xml 626 631 <span type="species:ncbi:10090">mouse</span>
Purified anti-CD3 (145-2C11), purified anti-CD28 (37.51), anti-CD25 (3C7), biotin-conjugated anti-CD25 (7D4), fluorescein isothiocyanate-conjugated anti-CD4 (GK1.5), phycoerythrin-conjugated anti-CD25 (PC61), unconjugated, allophycocyanin- or phycoerythrin-conjugated anti-IL-2 (JES6-5H4), anti-IL-4 (11B11) and anti-IL-4Ralpha (mIL4R-M1) are from BD Biosciences. Anti-Foxp3 (FJK-16S) and anti-IL-7Ralpha (A7R34) are from eBiosciences. The anti-FITC Multisort kit, IL-2 secretion assay kit and anti-biotin microbeads were from Miltenyi Biotec. The IL-2 Quantikine enzyme-linked immunosorbent assay (ELISA) kit and recombinant mouse IL-2, IL-7, IL-4, IL-15 and IL-21 were purchased from R&D Systems. Cell cultures were performed in complete RPMI 1640 medium (Bio-Whittaker) supplemented with 10% (vol/vol) FCS, 100 U/ml of penicillin, 100 mug/ml of streptomycin, 2 mM glutamine, 10 mM HEPES, 1 mM sodium pyruvate and 50 muM beta-mercaptoethanol.
###end p 11
###begin title 12
Cell purification
###end title 12
###begin p 13
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 405 406 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 410 412 410 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 413 417 413 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 467 469 467 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 698 700 694 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 719 720 715 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 724 726 720 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Splenocytes were harvested from 5 to 12 week old mice. Erythrocytes were osmotically-lysed using Ack lysing buffer (Bio Whitaker) and single cell suspensions were incubated with FITC-conjugated anti-CD4 and biotin-conjugated anti-CD25 followed by incubation with anti-FITC microbeads. CD4+ T cells were then purified by magnetic isolation using the Auto MACS sorter (Miltenyi Biotec). For isolation of CD4+CD25+ Treg cells, after releasing the beads, the purified CD4+ T cell suspension was incubated with alpha-biotin microbeads followed by separation using the Auto MACS. In all the experiments 90 to 95% of these cells were positive for CD4 and CD25. The negative fractions were depleted of CD25+ cells to obtain CD4+CD25- cells.
###end p 13
###begin title 14
T cell death and co-culture assays
###end title 14
###begin p 15
###xml 1 5 1 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 25 29 25 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 234 235 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 239 241 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 261 265 251 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp</sub>
###xml 274 275 264 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 324 328 314 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 332 333 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 337 338 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 347 348 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 354 358 344 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 362 363 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 367 368 357 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 464 468 444 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 472 476 452 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 564 569 544 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 619 623 599 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 627 631 607 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 728 730 708 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1038 1043 1018 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1049 1050 1029 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1200 1201 1180 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1205 1207 1185 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1237 1239 1217 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
Tcon cells (6 x 104) or Treg were cultured in U-bottom 96-well plates in the presence of soluble 0.75 mug/ml alpha-CD3 and 3 mug/ml alpha-CD28 for 3-4 days. Death was measured by flow cytometry after 3 days. For co-culture assays, CD4+CD25- responder T cells (Tresp) (3 x 104) were cultured in U-bottom 96-well plates with Tcon (CD4+CD25-) (3 x 104) or Treg (CD4+CD25+) in the presence of soluble 0.5-0.75 mug/ml alpha-CD3 and 3-4 mug/ml alpha-CD28 for 2-4 days. Treg or Tcon cells were used in the co-culture with responders directly in U-bottom 96-well plates. Tresp cells were CFSE-labeled to distinguish them from Tcon or Treg cells in co-culture. Proliferation was also assayed by CFSE dilution. Cell death analyses of CFSE+ responders were performed based on forward scatter and propidium iodide staining. All flow cytometry analyses assessing cell death were performed with events acquired at constant time, in order to count the events. The percentage of survival (Survival (%)) in all analyses is the percentage of cells that FSChigh and PI-. When indicated, IL-2 (1000 U/ml), IL-7 (20 ng/ml), IL-4 (20 ng/ml), IL-15 (20 ng/ml), IL-21 (20 ng/ml) was added. For IL-2 blocking experiments, CD4+CD25- cells were isolated and 6 x 104 cells were stimulated with anti-CD3 and anti-CD28 in the presence of isotype control or cytokine blocking antibodies, 10 mug/ml each, and cultured in 96-well U-bottomed plate.
###end p 15
###begin title 16
Electron microscopy
###end title 16
###begin p 17
###xml 1 5 1 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 9 13 9 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
Tcon or Treg cells isolated from cultures were washed with PBS twice, fixed with fixation buffer containing Glutaraldehyde and Sodium Cacodylate. Fixed cells were pelleted and sent to electron microscopy facility at SAIC-Frederick, Inc. for imaging and analyses.
###end p 17
###begin title 18
Results and Discussion
###end title 18
###begin title 19
###xml 57 61 57 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Gamma chain cytokines are essential for the survival of Treg cells in vitro
###end title 19
###begin p 20
###xml 28 32 28 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 102 105 102 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con</sub>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 122 125 122 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 355 359 355 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 490 500 490 500 <bold xmlns:xlink="http://www.w3.org/1999/xlink">left panel</bold>
###xml 504 508 504 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 626 636 626 636 <bold xmlns:xlink="http://www.w3.org/1999/xlink">left panel</bold>
###xml 672 674 668 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
###xml 793 797 789 793 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 863 867 859 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 933 935 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 937 948 933 944 <bold xmlns:xlink="http://www.w3.org/1999/xlink">right panel</bold>
###xml 987 989 979 981 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
###xml 1041 1045 1033 1037 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1057 1059 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 1061 1072 1053 1064 <bold xmlns:xlink="http://www.w3.org/1999/xlink">right panel</bold>
###xml 1188 1192 1180 1184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1266 1270 1258 1262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 1306 1308 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 1342 1346 1334 1338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1475 1477 1467 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 1479 1493 1471 1485 <bold xmlns:xlink="http://www.w3.org/1999/xlink">data not shown</bold>
###xml 1562 1564 1550 1552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
###xml 1717 1721 1705 1709 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1736 1744 1724 1732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1759 1761 1747 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 1792 1796 1780 1784 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 1896 1900 1884 1888 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1961 1965 1949 1953 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2001 2003 1989 1991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2066 2070 2054 2058 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2143 2145 2131 2133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2159 2161 2147 2149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 2192 2194 2180 2182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2238 2242 2226 2230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2256 2260 2244 2248 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2350 2354 2338 2342 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 2479 2483 2467 2471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2542 2544 2530 2532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2558 2560 2546 2548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1d</xref>
###xml 2611 2615 2599 2603 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 2671 2675 2659 2663 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2735 2737 2723 2725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2751 2753 2739 2741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1d</xref>
###xml 2811 2815 2799 2803 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2905 2906 2893 2894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 2979 2982 2967 2970 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 3110 3112 3098 3100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1e</xref>
###xml 3117 3119 3105 3107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1f</xref>
###xml 3148 3152 3136 3140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 3213 3221 3201 3209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 3270 3274 3258 3262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 3299 3300 3283 3284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 3424 3428 3408 3412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 3531 3535 3515 3519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 3654 3656 3638 3640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 3686 3688 3670 3672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 3757 3759 3737 3739 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c </sub>
###xml 3835 3839 3815 3819 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 3310 3314 <span type="species:ncbi:10090">mice</span>
###xml 3680 3684 <span type="species:ncbi:10090">mice</span>
To examine the survival of Treg cells in vitro, we used magnetically sorted CD4+CD25-Foxp3- T cells (Tcon) or CD4+CD25+ (Treg) cells and cultured with soluble anti-CD3 and anti-CD28 for 72-96 hours. We measured the frequency of surviving cells based on forward scatter and propidium iodide (PI) staining and flow cytometry analyses. There was a dramatic Treg cell death (75-90%) in the absence of IL-2 and increasing doses of IL-2 rescued them in a concentration dependent manner (Fig. 1a, left panel). Tcon cells survived well without exogenous IL-2 in the cultures, presumably because they produce IL-2 themselves (Fig. 1a, left panel). To test the effect of other gammac cytokines, we added IL-2, IL-4, IL-7, IL-15 or IL-21 at 20 ng/ml concentration during the beginning of stimulation in Treg cultures. We observed that the presence of the cytokines rescued Treg death, with IL-2 having the strongest pro-survival function (Fig. 1a, right panel). On the other hand, IL-23 a non-gammac cytokine did not have an effect on the survival of Treg cells (Fig. 1a, right panel). Carboxyfluorescein succinimidyl ester (CFSE) labeling of the cells showed that in the absence of cytokines, few Treg cells that remained in the culture did not undergo proliferation whereas Tcon cells proliferated vigorously (Fig. 1b). IL-2 induced proliferation in Treg cells whereas IL-4, IL-7, IL-15, IL-21 had minimal effect on proliferation even at the excessive concentration of 20 ng/ml (Fig. 1b, data not shown). However, the possibility that the combination of some or all gammac cytokines such as IL-4, IL-7, IL-15 and IL-21 could initiate proliferation in Treg cells is not excluded. As a control for CFSE staining, un-stimulated Treg cells isolated ex vivo is shown (Fig. 1b). Next, we hypothesized that Tcon cells producing IL-2 might also serve as IL-2 source and support the survival and proliferation of Treg cells in cultures. Therefore we stimulated the CFSE labeled Treg cells with increasing numbers of CD4+ T cells and analyzed their death after 72 hours. As expected, Treg cells died less and also proliferated in the presence of conventional CD4+ T cells (Fig. 1c). Even though conventional CD4+ T cells themselves died in the presence of Treg cells at CD4:Treg in 1:1 ratio, their viability was only mildly affected at 3:1 and 8:1 ratios. To test if Tcon induced survival was mediated by IL-2, we blocked IL-2 using a blocking antibody and found that the survival frequencies of Treg cells fell back to basal levels even in the presence of CD4+ T cells (Fig. 1d). However, the direct effect of blocking IL-2 in Tcon cells cannot be ruled out. The number of proliferating Treg cells was directly proportional to the numbers of viable CD4+ T cells (Fig. 1d). This is in accordance with our previous findings that Treg cells consume cytokines from conventional CD4 T cells, and in the process, suppress them [8]. Transmission electron microscopy and confocal microscopy analyses of Tregcells in the absence of cytokines showed condensed nuclei and membrane blebbing, the characteristic features of apoptosis (Fig. 1e and 1f). Thus, it is evident that Treg cells undergo apoptosis in the absence of cytokine signaling in vitro. Our findings corroborate the observation that Treg cells are absent in gammac-knockout mice, implying that gamma chain signaling is important not only for the development but also for the survival of Treg cells in the periphery. Our observation that gamma cytokines besides IL-2 can support the survival of Treg cells potentially explains previous observation that shows only a reduced frequency and not a complete absence of Foxp3+ cells in CD25 deficient mice [38]. In the absence of IL-2-R signaling, the combination of other gammac cytokines could also induce both survival and homeostatic proliferation of Treg cells in the periphery.
###end p 20
###begin p 21
###xml 30 34 30 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gamma chain cytokines rescue T<sub>reg </sub>cells from apoptosis <italic>in vitro</italic></bold>
###xml 65 69 65 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 83 87 83 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 91 95 91 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 210 214 210 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 312 316 312 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neg </sup>
###xml 323 327 323 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 382 386 382 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 461 465 461 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 522 523 522 523 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 556 560 556 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 564 568 564 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 593 601 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 622 623 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 695 696 695 696 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 725 729 725 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 832 834 832 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 882 886 882 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 912 914 912 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1075 1078 1074 1077 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a-c</bold>
###xml 1117 1118 1116 1117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1155 1157 1154 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1158 1162 1157 1161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1231 1233 1230 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1281 1283 1280 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1311 1315 1310 1314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1377 1378 1376 1377 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1413 1414 1412 1413 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1442 1446 1441 1445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 1450 1454 1449 1453 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1479 1483 1478 1482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1615 1616 1614 1615 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
Gamma chain cytokines rescue Treg cells from apoptosis in vitro. (a) Viability of Tcon or Treg cells stimulated for four days with soluble anti-CD3 and anti-CD28. IL-2 was added at indicated concentrations in Treg cultures at the beginning of stimulation (left panel). Percentages of events in the live gates (PIneg and FSChigh) in flow cytometric analyses are shown. Viability of Treg cells stimulated as in 'a'. Indicated cytokines were added at 20 ng/ml in Treg cultures at the beginning of stimulation (right panel). (b) Proliferation of CFSE labeled Tcon or Treg cells that were isolated ex vivo or stimulated as in 'a' with or without indicated cytokines, each at 20 ng/ml concentration. (c) Viability of CFSE labeled Treg cells that were stimulated as in 'a' and cultured without or with indicated numbers of conventional CD4+ T cells. CFSE labeling was done to distinguish Treg cells and conventional CD4+ T cells in the cultures. IL-2 and IL-2 receptors were blocked using blocking antibodies added at 10 mug/ml each, in the beginning of the stimulation. Data from (a-c) represent 3 independent experiments (d) Proliferation of CFSE labeled Foxp3+ Treg cells that were stimulated as in 'a' and cultured without or with CD4+ T cells at indicated ratios. Contaminating Foxp3- population in CFSE labeled Treg population is excluded in the analyses. Electron micrographs (e) or confocal microscopy analyses (f) of 2 or 3-day stimulated Tcon or Treg cells showing apoptotic Treg cells at different stages as defined by condensed, shrunken nuclei. (Blue = nuclei stained by 6-diamidino-2-phenylindole (DAPI) in (f).
###end p 21
###begin title 22
###xml 1 5 1 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Treg cells express cytokine receptors in vitro
###end title 22
###begin p 23
###xml 17 21 17 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 244 251 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 268 272 252 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 317 325 301 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a,b,c,d</xref>
###xml 376 380 356 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 385 389 365 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 512 516 488 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 646 650 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2e,f</xref>
###xml 655 657 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2g</xref>
###xml 659 681 627 649 <bold xmlns:xlink="http://www.w3.org/1999/xlink">upper and lower panels</bold>
###xml 714 718 682 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 754 758 722 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
To determine if Treg cells express the receptors for cytokines in addition to IL-2R-alpha CD25, splenocytes were isolated from Foxp3-eGFP mice and stained for cytokine receptors such as IL-4R-alpha (CD124), IL-7R-alpha (CD127) and IL-15R-alpha ex vivo. We found that Treg express receptors for these cytokines (Figs. 2a,b,c,d). We could not detect IL-21R-alpha expression on Tcon and Treg cells, possibly due to the absence of good detecting antibody for mouse IL-21R-alpha (data not shown). We also found that Treg cells showed an upregulation of chemokine receptors such as CXCR4, CCR5 and CCR7 up on alpha-CD3 and alpha-CD28 stimulation (Fig. 2e,f and 2g, upper and lower panels). These chemokine receptors on Treg cells are likely important for the Treg cells to be recruited to the chemokine and possibly also cytokine producing cells at the sites of inflammation.
###end p 23
###begin p 24
###xml 1 5 1 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T<sub>reg </sub>cells express cytokine and chemokine receptors <italic>ex vivo</italic></bold>
###xml 236 239 236 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a-d</bold>
###xml 291 293 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 295 298 295 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con</sub>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 310 313 310 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 339 346 339 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 349 352 349 352 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e-g</bold>
###xml 419 423 419 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 490 494 482 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
Treg cells express cytokine and chemokine receptors ex vivo. Expression of cytokine receptors on splenocytes isolated from Foxp3 GFP mice in which Foxp3 is expressed as a fusion protein with GFP. Grey curves indicate unstain controls. (a-d). Expression of indicated cytokine receptors on GFP- (Tcon) or GFP+ (Treg) of splenocytes isolated ex vivo. (e-g). Expression of indicated or chemokine receptors of unstimulated Treg cells (upper panels) or 3-day alpha-CD3 and alpha-CD28 stimulated Treg cells (lower panels). Results are representative of two independent experiments.
###end p 24
###begin title 25
###xml 1 5 1 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Treg cells die due to cytokine deprivation in vivo
###end title 25
###begin p 26
###xml 55 59 55 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 138 142 138 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 195 197 195 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 309 313 309 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 512 516 512 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 618 622 618 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 649 653 649 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
###xml 711 715 711 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 718 720 718 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 721 725 721 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 731 739 731 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3d</xref>
###xml 993 998 993 998 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 1063 1067 1063 1067 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 1079 1081 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3e</xref>
###xml 1086 1088 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3f</xref>
###xml 1131 1133 1131 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1134 1139 1134 1139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 1155 1159 1155 1159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1172 1176 1172 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1177 1181 1177 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1232 1234 1232 1234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1263 1265 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3g</xref>
###xml 1305 1310 1305 1310 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 1340 1344 1340 1344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1401 1405 1401 1405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1538 1540 1538 1540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1543 1545 1543 1545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1546 1551 1546 1551 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 1585 1587 1585 1587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1590 1592 1590 1592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1593 1598 1593 1598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 219 234 <span type="species:ncbi:10090">transgenic mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
To further assess the role of apoptosis in regulating Treg cells in vivo, we determined the role of B cell lymphoma-2 (Bcl-2) protein in Treg death. To this end, we measured the frequency of CD25+ Foxp3+ cells in Bcl-2 transgenic mice in CD45.1 background. We found that there was an increased percentage of Treg cells in these mice (Fig. 3a). The specific role of Bcl-2 interacting member (Bim) protein in mediating cytokine deprivation apoptosis is well documented [39]. Therefore, we tested the frequency of Treg cells in Bim deficient mice. Surprisingly, we also found that there was an increased accumulation of Treg cells in the spleens of Bim-/- mice (Fig. 3b and 3c). Furthermore, when we stimulated Bim-/- CD4+ Treg cells in vitro, we found that they had increased resistance to death in the absence of cytokines (Fig. 3d). However, their suppressive phenotype remained intact in the absence of Bim. They induced a partial suppression in proliferation and cell death of CFSE labeled Tresp cells that were co-cultured with them as compared to those with Tcon cells (Fig. 3e and 3f). In addition to causing cell death in CD4+ Tresp cells, both WT Treg cells and BIM-/- Treg cells were able to induce Foxp3 in conventional CD4+ T cells in co-cultures (Fig. 3g). The relevance of Foxp3 induction in Tresp cells due to the presence of Treg cells is unknown presently. However, in the presence of Treg cells and IL-7, the frequency of induced Foxp3+ cells seems to be diminished, probably due to an increased proliferation of non Foxp3+ CD4+ Tresp cells as compared to induced Foxp3+ CD4+ Tresp cells in the presence of IL-7.
###end p 26
###begin p 27
###xml 1 5 1 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T<sub>reg </sub>cells are susceptible to cytokine deprivation apoptosis <italic>in vivo</italic></bold>
###xml 71 72 71 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 127 129 127 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 191 198 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 200 204 200 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 228 232 228 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 265 267 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 272 274 272 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 318 322 318 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 328 336 328 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 337 338 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 360 364 360 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 404 408 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 507 508 507 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 524 528 524 528 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 532 536 532 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 556 560 556 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 757 761 757 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neg </sup>
###xml 768 773 768 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 832 837 832 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 844 845 844 845 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 874 879 874 879 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 886 887 886 887 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 920 924 920 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 934 938 934 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 973 977 973 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 999 1000 999 1000 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 1064 1069 1064 1069 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 1116 1120 1116 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1136 1140 1136 1140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 1144 1148 1144 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1172 1173 1172 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
Treg cells are susceptible to cytokine deprivation apoptosis in vivo. (a) Frequency of CD4+ Foxp3+ (upper panels) or CD25+Foxp3+ (lower panels) in splenocytes isolated from WT, Bcl-2 tg mice ex vivo. (b) Splenocytes of WT or Bim-/- mice showing the frequency of CD4+ Foxp3+ (upper panel) or CD25+Foxp3+ (lower panel) Treg cells ex vivo (c) Mean percentage of Treg cells in spleens of WT (grey bar) or Bim-/- mice (solid black bar) (n = 3-5, n = number of mice). Data represent two independent experiments. (d) Viability of Tcon or Treg cells from WT or Bim-/- mice stimulated for 3 days with soluble anti-CD3 and anti-CD28. Cytokines were added at indicated 20 ng/ml concentrations in cultures at the beginning of stimulation. Percentage of events in the PIneg and FSChigh live gates are shown. Histograms of CFSE dilution of live Tresp cells (e) and level of apoptosis in Tresp cells (f) from WT mice co-cultured with Tcon cells or Treg cells from WT (upper panels) or Bim-/- (lower panels) mice. (g) Dot plots showing Foxp3 expression and CFSE dilution in live Tresp cells co-cultured with WT (upper panels) or BIM-/- (lower panels) Tcon or Treg cells stimulated as in 'd' for 4 days in the presence or absence of IL-7 (20 ng/ml).
###end p 27
###begin title 28
###xml 61 65 61 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
Gamma chain cytokines maintain CD25 and Foxp3 expression in Treg cells
###end title 28
###begin p 29
###xml 59 63 59 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 159 163 159 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 303 307 303 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 323 339 323 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink">two upper panels</bold>
###xml 435 439 435 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 450 454 450 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 470 486 470 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">two upper panels</bold>
###xml 533 537 533 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 538 542 538 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 645 661 645 661 <bold xmlns:xlink="http://www.w3.org/1999/xlink">two lower panels</bold>
###xml 690 694 690 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 795 798 795 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 799 803 799 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 912 916 912 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 917 921 917 921 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 933 935 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 967 971 967 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 972 976 972 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 1005 1007 1005 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1221 1225 1221 1225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1286 1290 1286 1290 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1447 1451 1447 1451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1452 1455 1452 1455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 1199 1207 <span type="species:ncbi:405018">cardinal</span>
Because CD25 and Foxp3 are important for the function for Treg cells, we tested the influence of gamma chain cytokines on the expression for these molecules. Treg cells stimulated without any cytokine showed a substantial down-regulation of the CD25 expression whereas CD25 up-regulation was normal on Tcon cells (Fig. 4a, two upper panels). In the presence of cytokines however, CD25 expression was maintained at high levels both on Tcon cells and Treg cells (Fig. 4a, two upper panels). CD25 down regulation was only partial on BIM-/- Treg cells in the absence of cytokines, but was further up-regulated in the presence of cytokines (Fig. 4a, two lower panels). We also found that in WT Treg cells, Foxp3 was down regulated in the absence of cytokines whereas Foxp3 levels remained high in Bim-/-Treg cells upon TCR stimulation (Fig. 4b). Cytokines maintained high levels of Foxp3 expression both in WT and Bim-/- Treg cells (Fig. 4b). On the other hand, WT and Bim-/- Tcon population had only few Foxp3+ cells upon TCR stimulation, and was not up-regulated in the presence of cytokines. These findings demonstrate that cytokines are crucial not only for the survival but also for maintaining the cardinal features of Treg cells i.e the expression of CD25 and Foxp3. We believe that Treg cells lose the expression of Foxp3 due to the initiation of death signals in the absence of cytokines because it did not occur in the absence of death in Bim-/- Tregcells.
###end p 29
###begin p 30
###xml 61 65 61 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gamma chain cytokines maintain CD25 and Foxp3 expression in T<sub>reg </sub>cells</bold>
###xml 103 104 103 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 116 117 116 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 129 133 129 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 137 141 137 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 180 184 180 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 385 390 385 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 391 392 391 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 402 407 402 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 408 409 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
Gamma chain cytokines maintain CD25 and Foxp3 expression in Treg cells. Histograms of CD25 expression (a) or Foxp3 (b), of live Tcon or Treg cells from WT (two upper panels) or Bim-/- (two lower panels) mice stimulated for 3 days with soluble anti-CD3 and anti-CD28. Cytokines were added at indicated 20 ng/ml concentrations in cultures at the beginning of stimulation. Gates show CD25high (a) or Foxp3high (b) cells.
###end p 30
###begin title 31
###xml 43 47 43 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
Foxp3 dictates the cytokine dependence in Treg cells
###end title 31
###begin p 32
###xml 169 177 169 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 190 192 190 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 254 256 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 260 262 260 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 385 390 385 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 416 420 416 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 464 466 464 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 557 559 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 636 640 636 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 718 720 718 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 847 851 847 851 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 930 934 930 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 988 990 988 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1024 1028 1024 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 1074 1078 1074 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
###xml 1189 1191 1189 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1287 1289 1287 1289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1446 1451 1446 1451 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 1496 1498 1496 1498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1534 1536 1534 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1559 1561 1559 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5d</xref>
###xml 1586 1588 1586 1588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1760 1764 1760 1764 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1785 1787 1785 1787 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1897 1901 1897 1901 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1940 1942 1940 1942 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1987 1989 1987 1989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1993 1995 1993 1995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 2053 2054 2053 2054 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2060 2062 2060 2062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 2074 2076 2074 2076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4e</xref>
###xml 2191 2193 2191 2193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 2194 2196 2194 2196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 2225 2229 2225 2229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2242 2244 2242 2244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 2245 2247 2245 2247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 2318 2322 2318 2322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2424 2428 2424 2428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 2587 2591 2587 2591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
###xml 1318 1322 <span type="species:ncbi:10090">mice</span>
###xml 1512 1516 <span type="species:ncbi:10090">mice</span>
###xml 1548 1552 <span type="species:ncbi:10090">mice</span>
###xml 1606 1610 <span type="species:ncbi:10090">mice</span>
Scurfy mice carry a mutation in Foxp3 and succumb to a fatal autoimmune syndrome. We tested whether a strong dependence of cytokines was a characteristic feature of all ex vivo isolated CD25+ cells in general. We found that these Scurfy mice harbored CD4+ CD25+ cells that are presumably activated CD4+ T cells owing to the autoimmune condition of the mice (Fig. 5a). However, the CD25high cells that represent the Treg population was reduced from 16% to 8% in CD4+ population as compared to WT mice (Fig. 5a). However, there was a complete absence of Foxp3+ cells in these mice (Fig. 5b). To investigate whether Foxp3 is important in Treg cells for the extreme cytokine dependence for their survival, we isolated CD25+ cells from the Scurfy mice and tested their survival in the presence or in the absence of IL-2. We found that isolated Scurfy Tcon cells, when stimulated in cultures had an impaired survival as compared to WT Tcon cells. Surprisingly, however we found that Scurfy CD25+ cells survived as well as Scurfy Tcon cells even in the absence of IL-2 whereas WT Treg cells died substantially (Fig. 5c). Because of the lack of dependence on IL-2, we hypothesized that Scurfy CD25+ cells might not suppress other conventional T cells. To test this tenet, we co-cultured the CD25+ cells from WT mice or Scurfy mice with CFSE labeled CD4 T cells and measured the suppressive death after 3 days. Interestingly, we observed that responding Tresp cells underwent death in the presence of CD25+ cells from WT mice and not with CD25+ from Scurfy mice (Fig. 5d). It is likely that CD25+ cells from Scurfy mice produce cytokines due to the absence of Foxp3, which is why they do not depend on IL-2 added exogenously. To validate this theory, we stimulated WT Treg cells and scurfy CD25+ cells with anti-CD3 and anti CD28 and measured IL-2 in the supernatants after 3 days. We found that while WT Treg cells did not produce IL-2, Scurfy CD25+ cells produced as much cytokine as Scurfy CD4+ CD25- cells approaching the level of cytokine produced by WT CD4+, CD25- cells (Fig. 4e). This data is consistent with the previous observations showing suppressive effects of Foxp3 on IL-2 production [40,41] and the effect of IL-2 on Treg homeostasis [11,42]. Together, we show here that Foxp3 represses cytokine production in Treg cells, which is why they are dependent on gamma cytokines from an external source for survival. Thus Treg cells have a self-regulatory mechanism through which their inability to produce cytokines instruct them to depend on cytokines and without the cytokines, the Treg cells are deleted.
###end p 32
###begin p 33
###xml 60 64 60 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3 repression of IL-2 determines the IL-2 dependence in T<sub>reg </sub>cells</bold>
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 141 149 141 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 162 164 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 175 176 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 276 280 276 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 288 289 288 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 305 309 305 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 316 318 316 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 460 461 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 477 482 477 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 581 585 581 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 598 600 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 631 632 631 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 667 671 667 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">con </sub>
###xml 690 692 690 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
Foxp3 repression of IL-2 determines the IL-2 dependence in Treg cells. (a) Expression of CD25 on splenocytes isolated from WT or Scurfy mice ex vivo (gated on CD4+ T cells). (b) Expression of intracellular Foxp3 in splenocytes from WT or Scurfy mice showing the frequency of Treg cells. (c) Viability of Tcon or CD25+ cells from WT or Scurfy mice stimulated for 3 days with soluble anti-CD3 and anti-CD28 with or without IL-2 added at 20 ng/ml concentration. (d) Viability of Tresp cells from WT mice stimulated for 3 days with soluble anti-CD3 and anti-CD28 and co-cultured with Tcon cells or CD25+ cells from WT or Scurfy mice. (e) ELISA quantification of IL-2 in Tcon (open bars) or CD25+ (solid bars) cells from WT or Scurfy mice, stimulated for 3 days with soluble anti-CD3 and anti-CD28.
###end p 33
###begin title 34
Conclusion
###end title 34
###begin p 35
###xml 105 109 105 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 257 261 257 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 318 326 314 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 357 361 353 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 400 404 396 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 488 492 484 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 510 514 506 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 528 532 524 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 577 585 573 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 693 697 685 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 850 854 842 846 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1044 1048 1036 1040 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1142 1146 1130 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1339 1343 1323 1327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1385 1389 1369 1373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
Taken together, our data have important implications in the understanding of behavior and regulation of Treg cells. Here, we demonstrate that Treg cells are highly susceptible to apoptosis in the absence of cytokines. This cytokine withdrawal apoptosis in Treg cells is substantially abolished by the gammac cytokines in vitro. Our data also reveal that Bim-/- mice accumulate higher frequencies of Treg cells showing the importance of cytokine withdrawal death in regulating peripheral Treg cells. Moreover, Treg cells from Bim-/- mice do not depend on cytokines for survival in vitro. In addition to enhancing their survival, the gammac cytokines also maintain CD25 and Foxp3 expression in Treg cells, thus maintaining their suppressive potential. Most importantly, our data show that Foxp3 appears to confer the inability to produce cytokines in Treg cells thus increasing their dependence to extra-cellular sources of cytokines for survival and function. We have described here a cytokine dependent homeostatic regulation mechanism of the Treg cells. Along with the self-peptides, the availability of gammac cytokines probably keeps the Treg numbers in constant check thus maintaining both protective and regulatory arms of the immune system in balance. Thus, our study highlights the important role of gammac cytokines in regulating Treg survival, opening new ways to manipulate Treg cells.
###end p 35
###begin title 36
Reviewers' comments
###end title 36
###begin title 37
Reviewer's report 1
###end title 37
###begin p 38
Dr Avinash Bhandoola, University of Pennsylvania School of Medicine, Philadelphia
###end p 38
###begin p 39
PA United States
###end p 39
###begin p 40
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3g</xref>
I thought there was plenty of interesting new data in this work. I have a few very minor comments that should be simple to deal with, and do not need to be published. 1) I thought the abstract somewhat repetitious in places. It could be shortened. 2) The figure legends do not clearly explain 3b, particularly the bottom 2 panels. 3) I did not understand the relevance of the right-most panels in Fig. 3g (WT or Bim-/- Treg + IL-7), particularly when compared to the two preceding panels (WT or Bim-/- Treg). Is it referred to at all in the text, or otherwise explained?
###end p 40
###begin title 41
Author response
###end title 41
###begin p 42
###xml 0 133 0 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Relevant changes are made in the abstract and more clarifications are included in the figure legends according to reviewer's comments</italic>
Relevant changes are made in the abstract and more clarifications are included in the figure legends according to reviewer's comments.
###end p 42
###begin title 43
Reviewer's report 2
###end title 43
###begin p 44
Fred Ramsdell, Associate Director, Zymogenetics, Seattle, WA 98102
###end p 44
###begin p 45
Overall, the manuscript is well-written and concise. The connection between g-c receptor signaling and apoptosis - and the distinction between these cytokines and proliferation - is a significant finding and generally well supported by the data. To date, the bulk of studies on Treg survival/activity and cytokines has focused on IL-2, and the extension to other gamma-c receptor using cytokines provides a more comprehensive analysis of this biology.
###end p 45
###begin p 46
###xml 30 31 30 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 519 521 519 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R </sub>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
###xml 1136 1151 <span type="species:ncbi:10090">transgenic mice</span>
Whilst the experiments in Fig 5 are an interesting attempt to address the function of Foxp3 with respect to cytokine dependence, the conclusions are not fully supported by the data. The abstract states that in scurfy mice, "Foxp3 increases their (CD25+ cells) dependence on cytokines by suppressing cytokine production in Treg cells." Whilst Foxp3 does appear to directly suppress cytokine production, it does so in any T cell and the major effect of lack of Foxp3 in scurfy mice would appear to be the absence of the TR lineage more broadly. Thus, this is not an appropriate way to test "whether Foxp3 is important in Treg cells for the extreme cytokine dependence for their survival" as these mice don't have Treg cells. Previous data has demonstrated that scurfy T cells do not express Foxp3, that they are CD25+ and that these cells do not have any Treg activity (Khattri, et. al.). In fact, these cells produce large amounts of IL-2 and many other cytokines. Importantly however, the cells remaining in scurfy mice do not appear to be in any way related to Treg cells. The data in the manuscript is consistent with data from Foxp3 transgenic mice in which Foxp3 levels are increased, but the actual number of Treg cells is decreased, as are their CD25 levels - perhaps due to Foxp3 inhibition of g-c derived (IL2 or other) secretion. This figure however does not seem necessary to me for the manuscript to be of interest.
###end p 46
###begin title 47
Author response
###end title 47
###begin p 48
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 130 132 130 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 1514 0 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">This data indicates that not all CD25<sup>+ </sup>cells consume and depend on cytokine in vitro. In the absence of Foxp3 in Scurfy mice, CD25<sup>+ </sup>cells do not depend on IL-2 and other cytokines and make cytokines themselves. Even though our data do not show that Foxp3 determines cytokine dependence directly, we feel that there is a strong implication that the presence of Foxp3 inversely correlates with cytokine production in Treg cells, based on the fact that Foxp3 expression is restricted to Treg cells in mice. The weakness in this experiment, and a point on which we agree with the reviewer, is that it is not clear that the CD25-expressing cells in the Scurfy mice are related to CD25-expressing Treg cells in WT mice. For example, if Treg cells are truly absent in Scurfy animals, then the CD25-expressing T cells could be from a completely different lineage of CD4+ T cells. In this case, we would be comparing different lineages and the results would not indicate a direct effect of FoxP3. Alternatively, it might be that the FoxP3-negative, CD25-expressing cells in Scurfy mice are cells that would otherwise would have become Tregs, then our data gives a better insight into the role of FoxP3. In either case, a cleaner experiment would be to perform a knockdown of FoxP3 in WT mouse Tregs and assess if they now produce cytokines at a normal level and are no longer susceptible to apoptosis in the absence of exogenous cytokines. We are working on executing this experiment in the future. However, the results in </italic>
###xml 1519 1520 1519 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1520 1877 1520 1877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">show that Foxp3 expression and function but not expression of cytokine receptors alone determines cytokine consumption. Sakaguchi and colleagues (Hori et al, 2003, Science) have shown that Foxp3 transduction alone converts normal T cell in to a Treg cell validating our finding that the function of Foxp3 is restricted to Treg cell. Therefore, we feel that </italic>
###xml 1882 1883 1882 1883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1883 1915 1883 1915 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> is necessary for the manuscript</italic>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
###xml 1278 1283 <span type="species:ncbi:10090">mouse</span>
This data indicates that not all CD25+ cells consume and depend on cytokine in vitro. In the absence of Foxp3 in Scurfy mice, CD25+ cells do not depend on IL-2 and other cytokines and make cytokines themselves. Even though our data do not show that Foxp3 determines cytokine dependence directly, we feel that there is a strong implication that the presence of Foxp3 inversely correlates with cytokine production in Treg cells, based on the fact that Foxp3 expression is restricted to Treg cells in mice. The weakness in this experiment, and a point on which we agree with the reviewer, is that it is not clear that the CD25-expressing cells in the Scurfy mice are related to CD25-expressing Treg cells in WT mice. For example, if Treg cells are truly absent in Scurfy animals, then the CD25-expressing T cells could be from a completely different lineage of CD4+ T cells. In this case, we would be comparing different lineages and the results would not indicate a direct effect of FoxP3. Alternatively, it might be that the FoxP3-negative, CD25-expressing cells in Scurfy mice are cells that would otherwise would have become Tregs, then our data gives a better insight into the role of FoxP3. In either case, a cleaner experiment would be to perform a knockdown of FoxP3 in WT mouse Tregs and assess if they now produce cytokines at a normal level and are no longer susceptible to apoptosis in the absence of exogenous cytokines. We are working on executing this experiment in the future. However, the results in Fig. 5show that Foxp3 expression and function but not expression of cytokine receptors alone determines cytokine consumption. Sakaguchi and colleagues (Hori et al, 2003, Science) have shown that Foxp3 transduction alone converts normal T cell in to a Treg cell validating our finding that the function of Foxp3 is restricted to Treg cell. Therefore, we feel that Fig. 5 is necessary for the manuscript.
###end p 48
###begin p 49
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a/b</xref>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4e/f</xref>
One further observation is that it appears to be very clear in Fig 3a/b that the amount of Foxp3 protein is substantially less in the Bcl-2 tg and Bim -/- Treg cells than in conventional cells (although this is less evident in Fig 4). Previous data has suggested that the absolute amount of Foxp3 can be a critical factor in regulating the amount of suppressive activity by Treg cells, and the functional data in Fig 4e/f would support this. But I am unclear why, in the model proposed, there might be less Foxp3 protein in cells from these animals and I would be interested to hear the author's speculation on this.
###end p 49
###begin title 50
Author response
###end title 50
###begin p 51
###xml 143 147 143 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 215 219 215 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 232 236 232 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 0 393 0 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">We speculate that Treg cells in Bcl-2 tg and Bim-/- mice, do not die even when cytokine levels are less abundant resulting in accumulation of T<sub>reg </sub>cells. Therefore, the available cytokines are being shared by more T<sub>reg </sub>cells. Each T<sub>reg </sub>cell could potentially be exposed to lower amounts of cytokines, which possibly results in Foxp3 downregulation (because cytokines maintain Foxp3 expression)</italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
We speculate that Treg cells in Bcl-2 tg and Bim-/- mice, do not die even when cytokine levels are less abundant resulting in accumulation of Treg cells. Therefore, the available cytokines are being shared by more Treg cells. Each Treg cell could potentially be exposed to lower amounts of cytokines, which possibly results in Foxp3 downregulation (because cytokines maintain Foxp3 expression).
###end p 51
###begin title 52
Some minor points for consideration
###end title 52
###begin p 53
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Although correct as written, it might be more informative to indicate in the abstract that ANY g-c using cytokine protects Treg cells from apoptosis - although only IL2 appears to be capable of inducing proliferation. This distinction is one of the more salient features of the article. It seems appropriate to reference the work of Malek and colleagues (particularly Bayer, Yu and Malek, JI, 2007) when referring to previous studies on the role of IL-2 and Treg development (eg, in reference to Fig 1). In Figure 2, for panels e-g, please clarify the conditions for the upper versus lower histograms (presumably resting versus activated). I declare that I have no competing interests.
###end p 53
###begin title 54
Author response
###end title 54
###begin p 55
###xml 0 129 0 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The abstract has been rewritten reiterating the differential effects of gamma chain cytokines on survival and proliferation. The </italic>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 138 228 138 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> legend has been modified and the Malek reference is included as suggested by the reviewer</italic>
The abstract has been rewritten reiterating the differential effects of gamma chain cytokines on survival and proliferation. The Figure. 2 legend has been modified and the Malek reference is included as suggested by the reviewer.
###end p 55
###begin title 56
Reviewer's report 3
###end title 56
###begin p 57
Anne Cooke, University of Cambridge, Department of Pathology, Tennis Court Rd
###end p 57
###begin p 58
Cambridge, CB21QP, United Kingdom
###end p 58
###begin p 59
###xml 101 103 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 107 109 103 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 114 116 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
In this manuscript the authors have examined the role of common gamma chain (gammac) cytokines in CD4+ CD25+ Foxp3+ T cell survival. They clearly show that cytokines other than IL-2 that signal through the gammac prevent apoptosis of T reg cells following stimulation with alphaCD3 and alphaCD28. This provides a nice explanation for the presence of T reg in CD25 deficient mice. While addition of exogenous gammac cytokines enabled T reg survival, they are proposed individually not to be as effective as IL-2. This reviewer was unclear whether all the cytokines had been titrated to determine efficacy. Were the cytokines titrated fully and were doses greater than 20 ng/ml used?
###end p 59
###begin title 60
Author response
###end title 60
###begin p 61
###xml 0 148 0 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">All cytokines were used at 20 ng/ml, which is an excessive amount in culture of 60,000 cells based on established biologically active concentrations</italic>
All cytokines were used at 20 ng/ml, which is an excessive amount in culture of 60,000 cells based on established biologically active concentrations.
###end p 61
###begin p 62
###xml 134 138 <span type="species:ncbi:10090">mice</span>
The link to apoptosis in Treg survival was nicely further substantiated by studies using T reg from Bcl-2 transgenic or BIM deficient mice. It appeared that there was some induction of Foxp3 expression in responding cells co-cultured with Treg. Was this TGFbeta and/or cell contact dependent? The authors do not comment on the ability of IL-7 to reverse this.
###end p 62
###begin title 63
Author response
###end title 63
###begin p 64
###xml 46 51 46 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 237 241 234 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 374 376 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 379 381 376 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 382 387 379 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 421 423 418 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 426 428 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 429 434 426 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">resp </sub>
###xml 0 564 0 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">We did not test if the induction of Foxp3 in T<sub>resp </sub>cells was TGF-&#946; dependent as it was not the focus of the current study. It is an interesting experiment for the future and we appreciate this suggestion. However, in the presence of T<sub>reg </sub>cells and IL-7, the frequency of induced Foxp3+ cells seems to be diminished, probably due to an increased proliferation of non Foxp3<sup>+ </sup>CD4<sup>+ </sup>T<sub>resp </sub>cells as compared to induced Foxp3<sup>+ </sup>CD4<sup>+ </sup>T<sub>resp </sub>cells in the presence of IL-7. We have included this comment in the last sentence of the relevant paragraph in the results section</italic>
We did not test if the induction of Foxp3 in Tresp cells was TGF-beta dependent as it was not the focus of the current study. It is an interesting experiment for the future and we appreciate this suggestion. However, in the presence of Treg cells and IL-7, the frequency of induced Foxp3+ cells seems to be diminished, probably due to an increased proliferation of non Foxp3+ CD4+ Tresp cells as compared to induced Foxp3+ CD4+ Tresp cells in the presence of IL-7. We have included this comment in the last sentence of the relevant paragraph in the results section.
###end p 64
###begin p 65
The final observation that Foxp3 expression suppresses cytokine production in T reg cells is interesting and in line with the studies of others. It was somewhat surprising that the work of others was not mentioned and the data from this current submission not situated in the context of the studies by Sakaguchi and his colleagues (Ono et al (2007) Nature 446:685-689.) showing Runx1 interaction with FoxP3 and inhibition of IL-2 gene transcription as well as others. Rao and colleagues (Wu et al Cell 2006) had also previously predicted an effect of FoxP3/NFAT interaction on the transcription of several genes including IL-2. The manuscript would have been improved by including some discussion of these.
###end p 65
###begin title 66
Author Response
###end title 66
###begin p 67
###xml 0 77 0 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">References and discussion are included as per the suggestions of the reviewer</italic>
References and discussion are included as per the suggestions of the reviewer.
###end p 67
###begin title 68
Competing interests
###end title 68
###begin p 69
The author(s) declare that they have no competing interests.
###end p 69
###begin title 70
Authors' contributions
###end title 70
###begin p 71
PP designed the study and performed the experiments under the supervision of MJL. The manuscript was written by PP and MJL.
###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
The authors thank Lixin Zheng, Carol Trageser and other members of the Lenardo laboratory for discussion and help. We thank Owen Schwartz and Meggan Czapiga for their help in confocal microscopy and Kunio Nagashima for assistance in electron microscopy. This work was supported by the intramural research program of NIAID, NIH. P.P is supported by a National Academy of Sciences/National Research Council fellowship.
###end p 73
###begin article-title 74
Foxp3 occupancy and regulation of key target genes during T-cell stimulation
###end article-title 74
###begin article-title 75
The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells
###end article-title 75
###begin article-title 76
###xml 40 45 <span type="species:ncbi:9606">human</span>
Role of regulatory T cells and FOXP3 in human diseases
###end article-title 76
###begin article-title 77
FOXP3+ regulatory T cells: Current controversies and future perspectives
###end article-title 77
###begin article-title 78
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
###end article-title 78
###begin article-title 79
Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells
###end article-title 79
###begin article-title 80
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
###end article-title 80
###begin article-title 81
CD4(+)CD25(+)Foxp3(+) regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4(+) T cells
###end article-title 81
###begin article-title 82
Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells
###end article-title 82
###begin article-title 83
Immunology. Regulating the regulators
###end article-title 83
###begin article-title 84
Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
###end article-title 84
###begin article-title 85
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
###end article-title 85
###begin article-title 86
Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment
###end article-title 86
###begin article-title 87
Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system
###end article-title 87
###begin article-title 88
Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells
###end article-title 88
###begin article-title 89
Regulatory T cells are resistant to apoptosis via TCR but not P2X7
###end article-title 89
###begin article-title 90
A function for interleukin 2 in Foxp3-expressing regulatory T cells
###end article-title 90
###begin article-title 91
###xml 19 24 <span type="species:ncbi:9606">human</span>
The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro
###end article-title 91
###begin article-title 92
Overview of interleukin-2 function, production and clinical applications
###end article-title 92
###begin article-title 93
Cytokines and T-cell homeostasis
###end article-title 93
###begin article-title 94
Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis
###end article-title 94
###begin article-title 95
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells
###end article-title 95
###begin article-title 96
T-cell turnover in vivo and the role of cytokines
###end article-title 96
###begin article-title 97
Signaling T-cell survival and death by IL-2 and IL-15
###end article-title 97
###begin article-title 98
Gamma c cytokines condition the progressive differentiation of CD4+ T cells
###end article-title 98
###begin article-title 99
Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID)
###end article-title 99
###begin article-title 100
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
###end article-title 100
###begin article-title 101
Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor
###end article-title 101
###begin article-title 102
Common gamma chain cytokines: dissidence in the details
###end article-title 102
###begin article-title 103
Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways
###end article-title 103
###begin article-title 104
Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling
###end article-title 104
###begin article-title 105
IL-7 is critical for homeostatic proliferation and survival of naive T cells
###end article-title 105
###begin article-title 106
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells
###end article-title 106
###begin article-title 107
IL-2 and autoimmune disease
###end article-title 107
###begin article-title 108
Natural regulatory T cells and self-tolerance
###end article-title 108
###begin article-title 109
Selection and behavior of CD4+ CD25+ T cells in vivo: lessons from T cell receptor transgenic models
###end article-title 109
###begin article-title 110
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms
###end article-title 110
###begin article-title 111
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells
###end article-title 111
###begin article-title 112
The role of BH3-only proteins in the immune system
###end article-title 112
###begin article-title 113
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1
###end article-title 113
###begin article-title 114
FOXP3 controls regulatory T cell function through cooperation with NFAT
###end article-title 114
###begin article-title 115
Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells
###end article-title 115

